STAT+: Top contributors to leading psychiatry journals fail to disclose industry payments, analysis finds

Amid ongoing concern over conflicts of interest that may affect medical practice, a new study found that 14% of the $4.5 million paid to authors in two leading psychiatry journals was undisclosed and nearly all of the payments were made to researchers conducting randomized controlled trials for pharmaceuticals.

All totaled, $206,000 paid to American Journal of Psychiatry authors, or 7.5% of total payments, was not disclosed, while $439,000, or 25% of the payments made to contributors of the Journal of the American Medical Association Psychiatry, was not disclosed. Total undisclosed payments among the top 10 highest-earning authors accounted for 85% and 99.6% of all payments that were not disclosed in the AJP and JAMA Psychiatry, respectively.

Among those who received undisclosed payments, 80% of the authors who contributed to JAMA Psychiatry and 36.3% of those who wrote for AJP received “substantial” undisclosed payments, defined as those exceeding $5,000, according to the National Institutes of Health threshold for a “significant financial interest.”

Continue to STAT+ to read the full story…